Ignite Creation Date:
2025-12-25 @ 12:03 AM
Ignite Modification Date:
2026-01-31 @ 4:59 AM
Study NCT ID:
NCT02222558
Status:
COMPLETED
Last Update Posted:
2016-05-30
First Post:
2014-08-18
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Oral Testosterone for the Treatment of Hypogonadism in Males
Sponsor:
TesoRx Pharma, LLC
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Hypogonadism | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | hypogonadism | View |
| None | Gonadal Disorders | View |
| None | Endocrine System Diseases | View |
| None | Testosterone | View |
| None | Testosterone enanthate | View |
| None | Testosterone undecanoate | View |
| None | Testosterone 17 beta-cypionate | View |
| None | Methyltestosterone | View |
| None | Androgens | View |
| None | Hormones | View |
| None | Hormones, | View |
| None | Hormone Substitutes, | View |
| None | Hormone Antagonists | View |
| None | Physiological Effects of Drugs | View |
| None | Pharmacologic Actions | View |
| None | Therapeutic Uses | View |
| None | Anabolic Agents | View |
| None | dihydrotestosterone | View |